Kazia Therapeutics (KZIA) Debt to Equity (2011 - 2025)
Kazia Therapeutics (KZIA) posted Debt to Equity of -$0.38 for Q2 2025, up 41.32% on a QoQ basis from -$0.65 in Q2 2024, and up 41.32% year-over-year from -$0.27 in Q2 2024.
Kazia Therapeutics (KZIA) has 6 years of Debt to Equity data on file, last reported at -$0.38 in Q2 2025.
- In Q2 2025, Debt to Equity rose 41.32% year-over-year to -$0.38; the TTM figure through Jun 2025 stood at -$0.38 (up 41.32% YoY), while the FY2025 annual figure was -$0.38, up 41.32% from the prior year.
- Debt to Equity grew to -$0.38 in Q2 2025, from -$0.65 in the prior quarter.
- Across five years, Debt to Equity topped out at $1.63 in Q4 2023 and bottomed at -$0.65 in Q2 2024.
- A 4-year average of $0.24 and a median of -$0.1 in 2022 frame the typical range for Debt to Equity.
- Annual changes were most pronounced in 2023 — Debt to Equity surged 808.34% — and 2024, when it tumbled 190.62%.
- Year by year, Debt to Equity stood at -$0.1 in 2022, then surged by 1720.56% to $1.63 in 2023, then sank by 139.61% to -$0.65 in 2024, then jumped by 41.32% to -$0.38 in 2025.
- The last three Debt to Equity figures came in at -$0.38 (Q2 2025), -$0.65 (Q2 2024), and $1.63 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.38 |
| Jun 30, 2024 | -0.65 |
| Dec 31, 2023 | 1.63 |
| Jun 30, 2023 | 0.71 |
| Jun 30, 2022 | -0.10 |
| Jun 30, 2018 | 0.00 |
| Jun 30, 2011 | 0.24 |